Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE)

SIMPLE SUMMARY: Advanced melanoma is a highly aggressive disease with a poor prognosis. Recent clinical trials have shown that targeted therapy (TT) and immunotherapy (IT) lead to significant improvements in responses to treatment and the survival of advanced melanoma patients. However, little infor...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlova, Kristina V., Ledin, Evgeniy V., Zhukova, Natalia V., Orlova, Rashida V., Karabina, Elena V., Volkonskiy, Mikhail V., Stroyakovskiy, Daniil L., Yurchenkov, Aleksandr N., Protsenko, Svetlana A., Novik, Alexey V., Vorotilina, Ludmila V., Moiseenko, Fedor V., Chang, Victor L., Kazmin, Aleksandr I., Tkachenko, Svetlana A., Gamaunov, Sergey V., Naskhletashvili, David R., Samoylenko, Igor V., Vikhrova, Anastasia S., Utyashev, Igor A., Kharkevich, Galina Yu., Petenko, Natalia N., Shubina, Irina Zh., Demidov, Lev V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196785/
https://www.ncbi.nlm.nih.gov/pubmed/34064013
http://dx.doi.org/10.3390/cancers13112529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196785/
https://www.ncbi.nlm.nih.gov/pubmed/34064013
http://dx.doi.org/10.3390/cancers13112529

Ejemplares similares